NCT02619240 Application of GeneXpert on Bronchoscopic Samples in the Clinical Management of Patients Suspicious of TB Status COMPLETED Phase N/A
NCT02606214 A Multiple Ascending Dose Study With a Dose Formulation Comparison Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects Status TERMINATED Phase PHASE1
NCT02605538 Hepatitis B in Cystic Fibrosis and Latent Tuberculosis Respectively Status WITHDRAWN Phase NA
NCT02602509 Evaluating Celecoxib Activity in Mycobacterium Tuberculosis: A Whole Blood Bactericidal Activity Study in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02583048 Evaluating the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid, Alone and in Combination, For Drug-Resistant Pulmonary Tuberculosis Status COMPLETED Phase PHASE2
NCT02581579 Study to Evaluate the Tolerability and Immunogenicity of Nyaditum Resae ® Probiotic Administered to Pediatric Population in Contact With Tuberculosis With or Without Latent Tuberculosis Infection Status COMPLETED Phase NA
NCT02563327 Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis Status COMPLETED Phase PHASE3
NCT02538952 Evaluating Accuracy, Impact, and Operational Challenges of GeneXpert Use for TB Case Finding Among HIV-infected Persons Status COMPLETED Phase PHASE4
NCT02534727 Sputum Pharmacokinetics of TB Drugs and Bacterial Drug Resistance Status COMPLETED Phase N/A
NCT02533089 Training Lay Healthcare Workers to Optimize TB Care and Improve Outcomes in Malawi Status COMPLETED Phase NA
NCT02532036 MVA85A Aerosol vs Intramuscular Vaccination in Adults With Latent Mycobacterium Tuberculosis (M. tb) Infection Status TERMINATED Phase PHASE1
NCT02512939 Predictive Values of Next Generation Interferon Gamma Release Assays for Latent Tuberculosis Infection Status COMPLETED Phase NA
NCT02508376 Safety, Tolerability, and Immunogenicity of the Vaccine Candidates ID93 + AP10-602 and ID93 + GLA-SE Administered Intramuscularly in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT02503839 Therapeutic Vaccination and Immune Modulation - New Treatment Strategies for the MDR Tuberculosis Pandemic Status COMPLETED Phase PHASE1